↓ Skip to main content

Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer

Overview of attention for article published in Journal of Pharmaceutical Health Care and Sciences, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 158)
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users
peer_reviews
1 peer review site

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer
Published in
Journal of Pharmaceutical Health Care and Sciences, April 2018
DOI 10.1186/s40780-018-0105-3
Pubmed ID
Authors

Kazuhide Tanaka, Akiyo Hori, Tomoya Tachi, Tomohiro Osawa, Katsuhiro Nagaya, Teppei Makino, Seiji Inoue, Masahiro Yasuda, Takashi Mizui, Takumi Nakada, Chitoshi Goto, Hitomi Teramachi

Abstract

In recent years, cancer chemotherapy is being conducted at outpatient clinics, wherein pharmacists are involved with patient guidance and management of adverse events as experts in medication therapy. Therefore, we clarified the influence of interventions by pharmacists during counseling of patients with cancer on patients' quality of life. To determine this influence, we conducted a survey to assess the quality of life of 39 patients with breast cancer who underwent their initial course of outpatient cancer chemotherapy at Gifu Municipal Hospital. A quality of life survey was conducted before the 1st, 2nd, and 3rd courses of treatment and was based on a method obtained from a survey paper entitled, "Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs." Twenty patients were assigned to the intervention group, which received pharmacist counseling, and nineteen patients were assigned to the non-intervention group, which received no pharmacist counseling. Both groups were compared immediately before the 1st course and 2nd course. Regarding the subscale of social relationships, a significant difference was observed for malaise (p = 0.043), with the non-intervention group experiencing them to a greater degree than the intervention group. Regarding the change between immediately before the 1st course and the 3rd course, a significant difference was observed in the subscale of social relationships for nausea (p = 0.017), with the non-intervention group experiencing it to a greater degree than the intervention group. The results suggest that receiving pharmacists' guidance on adverse events and individually adjusted prescriptions tailored to address the occurrence of adverse events improved the treatment environment and enhanced the quality of life in the intervention group. These findings are beneficial in maintaining patients' quality of life during cancer treatment. No. UMIN000027171, Registration date: Apr 27, 2017. Retrospectively registered.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 15%
Student > Bachelor 5 11%
Student > Ph. D. Student 4 9%
Lecturer 3 6%
Student > Doctoral Student 3 6%
Other 10 21%
Unknown 15 32%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 22 47%
Nursing and Health Professions 2 4%
Medicine and Dentistry 2 4%
Neuroscience 2 4%
Unspecified 1 2%
Other 4 9%
Unknown 14 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2019.
All research outputs
#3,382,328
of 25,608,265 outputs
Outputs from Journal of Pharmaceutical Health Care and Sciences
#14
of 158 outputs
Outputs of similar age
#65,119
of 339,152 outputs
Outputs of similar age from Journal of Pharmaceutical Health Care and Sciences
#2
of 2 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 158 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,152 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.